China International Capital Corp
-
Greater China issuers dominate this week’s supply, as rare Indian credit HDFC Bank also returns after almost a decade
-
-
Chinese stent maker dashes out for a listing before Christmas
-
Mala snacks maker has parked over half of its deal with cornerstones
-
The two firms are testing investor appetite for their listings
-
Chinese cancer immunotherapy drug producer parks over half of the deal with cornerstone investors
-
Gaush Meditech is seeking about $80m, and Weilong Global roughly $200m
-
Chinese insurance provider will start taking investor orders at the end of November
-
Chinese nickel producer's deal size takes a hit due to 'gloomy' market outlook
-
State-backed bank benefitted from a turn in sentiment towards Chinese credits
-
Rare deal is covered before launch but bankers warn the listing may be a 'one-off'
-
Greenfields's milk producer seeks to raise $50m-$70m
-
Chinese medical device company is seeking about $100m
-
-
Nickel miner gets a few cornerstones, but deal size is likely to be trimmed
-
Chinese outdoor apparel retailer is aiming for a listing worth at least $500m by year end
-
Chinese collagen skincare firm began pre-deal investor education on Monday
-
-
-
-
The metaverse focused company is finalising valuations and cornerstones before hitting the market
-
The Chinese investment bank is leading the league tables by deal flow and revenues
-
Bookbuilding is likely to launch next week, with bankers refuting rumours the IPO is on hold
-
Chinese commodities firms push ahead with relatively large deals amid lacklustre IPO market